Alleghany Corporation’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$118M Hold
721,851
5.32% 7
2022
Q2
$128M Hold
721,851
4.85% 7
2022
Q1
$128M Hold
721,851
4.04% 11
2021
Q4
$123M Hold
721,851
3.59% 14
2021
Q3
$117M Sell
721,851
-107,889
-13% -$18.4M 3.59% 12
2021
Q2
$137M Sell
829,740
-71,260
-8% -$11.8M 4.07% 9
2021
Q1
$148M Buy
901,000
+325,562
+57% +$52.7M 4.74% 5
2020
Q4
$90.6M Buy
+575,438
New +$84.9M 3.6% 14
2015
Q2
Sell
-30,000
Closed -$3.02M 43
2015
Q1
$3.02M Hold
30,000
0.11% 34
2014
Q4
$3.14M Hold
30,000
0.12% 35
2014
Q3
$3.2M Hold
30,000
0.12% 31
2014
Q2
$3.14M Hold
30,000
0.11% 33
2014
Q1
$2.95M Hold
30,000
0.12% 33
2013
Q4
$2.75M Hold
30,000
0.13% 36
2013
Q3
$2.6M Hold
30,000
0.14% 36
2013
Q2
$2.58M Buy
+30,000
New +$2.55M 0.15% 30

Other funds holding JNJ

Alleghany Corporation's JNJ Position: Q3 2022 in Review

Alleghany Corporation held its Johnson & Johnson (JNJ) position steady in Q3 2022 at 721,851 shares worth $118M. The position accounts for 5.32% of the portfolio, ranked #7.

Alleghany Corporation first reported a position in JNJ in Q2 2013 and has held it in 16 quarters since. The position peaked at $148M in Q1 2021. 3,624 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Alleghany Corporation held 721,851 shares of Johnson & Johnson worth $118M as of Q3 2022.
  • Alleghany Corporation left its Johnson & Johnson share count unchanged in Q3 2022.
  • Johnson & Johnson made up 5.32% of Alleghany Corporation's portfolio in Q3 2022, its #7 holding.
  • Alleghany Corporation first reported a position in Johnson & Johnson in Q2 2013 and has held it in 16 quarters since.
  • Alleghany Corporation's Johnson & Johnson position peaked at $148M in Q1 2021.
  • 3,624 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Alleghany Corporation's 13F filing for Q3 2022, filed 1 Nov 2022.